- LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin
- 点击次数：
- 所属单位：药学院
- 发表刊物：《Invest New Drugs》
- 全部作者：程艳娜
- 第一作者：曲显俊
- 论文类型：基础研究
- 论文编号：lw-104094
- 卷号：29
- 期号：12
- 页面范围：574
- 是否译文：否
- 发表时间：2011-08-23
上一条： TMPDP, a tetramethylpyrazine derivative, protects vascular endothelial cells from oxidation damage by hydrogen peroxide.
下一条： Sulfated polysaccharide of Sepiella Maindroni ink inhibits the migration, invasion and matrix metalloproteinase-2 expression through suppressing EGFR-mediated p38/MAPK and PI3K/Akt/mTORsignaling pathways in SKOV-3 cells
